Ryan advises a wide range of clients across the life sciences and technology industries on capital markets and corporate matters. He has worked closely with executives, boards of directors and underwriters to provide thoughtful counseling in capital market transactions and corporate governance matters. Ryan’s extensive experience includes representing companies, investors and underwriters in all manner of capital market transactions, including IPOs, reverse mergers, ATM offerings, PIPE offerings, SPAC mergers, convertible debt and other financings. Ryan also advises public companies on various general corporate and securities law matters, including corporate governance best practices, ESG best practices, compliance with stock exchange rules and securities laws, and periodic reporting obligations. Ryan has also been at the forefront in guiding blockchain companies through SEC registration and securities compliance matters.